15 Five years of exemestane as initial therapy compared to tamoxifen followed by exemestane for a total of 5 years: the TEAM trial, a prospective, randomized, phase III trial in postmenopausal women with hormone receptor-positive early breast cancer

✍ Scribed by A. Hasenburg; C.J.H. van de Velde; C. Seynaeve; D.W. Rea; J. Vannetzel; R. Paridaens; C. Markopoulos; Y. Hozumi; H. Putter; S.E. Jones

• Book ID: 119601033
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 46 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)70047-1